Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART
Clinical trial NCT00038532 · COMPLETED
Trial details
- NCT number
- NCT00038532
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-04-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.